Wed, October 4, 2023

Joseph Pantginis Maintained (CAPR) at Strong Buy with Increased Target to $40 on, Oct 4th, 2023

Joseph Pantginis of HC Wainwright & Co., Maintained "Capricor Therapeutics, Inc." (CAPR) at Strong Buy with Increased Target from $18 to $40 on, Oct 4th, 2023.

Joseph, nor any peers, have made any analyst calls on CAPR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30